Aesthetic procedures in office practice

American Family Physician

Volumn 80, Issue 11, 2009, Pages 1231-1237

  Small, Rebecca ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

BLEPHAROSPASM; DRUG APPROVAL; DRUG EFFECT; DYSTONIA; ESTHETICS; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERHIDROSIS; MEDICAL PRACTICE; MIGRAINE; MORBIDITY; PHOTOAGING; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; REVIEW; SPASTICITY; STRABISMUS;

EID: 72049091230     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. American Society for Aesthetic Plastic Surgery.Cosmetic Surgery National Data Bank 2008 Statistics. New York, NY: American Society for Aesthetic Plastic Surgery; 2008. http://www.surgery.org/media/statistics. Accessed September 17, 2009.
2. Carruthers JD, Glogau RG, Blitzer A, for the Facial Aesthetics Consensus Group Faculty. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies - consensus recommendations. Plast Reconstr Surg. 2008;121(5 suppl):5S-36S.
3. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol. 1996;132(4):395-402. (Pubitemid 26113388)
4. Coleman WP III, Yarborough JM, Mandy SH. Dermabrasion for prophylaxsis and treatment of actinic keratoses. Dermatol Surg. 1996;22(1):17-21.
5. Fedok FG. Advances in minimally invasive facial rejuvenation. Curr Opin Otolaryngol Head Neck Surg. 2008;16(4):359-368.
6. de Maio M. The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg. 2004;28(5):295-300.
7. Sommer B, Zschocke I, Bergfeld D, Sattler G, Augustin M. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol Surg. 2003;29(5):456-460. (Pubitemid 36583141)
8. Carruthers J, Fagien S, Matarasso SL, for the Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114(6 suppl):1S-22S.
9. Wise JB, Greco T. Injectable treatments for the aging face. Facial Plast Surg. 2006;22(2):140-146.
10. Sarkar P, Hirsch RJ. Update on laser hair removal. Cosmet Dermatol. 2007;20(7):440-444.
11. Ross EV, Smirnov M, Pankratov M, Altshuler G. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons. Dermatol Surg. 2005;31(9 pt 2):1188-1198. (Pubitemid 41587069)
12. Grimes PE. Microdermabrasion. Dermatol Surg. 2005;31(9 pt 2):1160-1165.
13. Zakopoulou N, Kontochristopoulous G. Superficial chemical peels. J Cosmet Dermatol. 2006;5(3):246-253.
14. Carruthers A, Carruthers J, Cohen J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol Surg. 2003;29(5):461-467. (Pubitemid 36583142)
15. Ogden S, Griffiths TW. A review of minimally invasive cosmetic procedures. Br J Dermatol. 2008;159(5):1036-1050.
16. Zimbler MS, Kokoska MS, Thomas JR. Anatomy and pathophysiology of facial aging. Facial Plast Surg Clin North Am. 2001;9(2):179-187
17. Sadick NS. A structural approach to nonablative rejuvenation. Cosmet Dermatol. 2002;15(12):39-43.
18. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1994;44(12):2401-2403.
19. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323(7313):596-599. (Pubitemid 32846124)
20. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the Botox Migraine Clinical Research Group. Headache. 2000;40(6):445-450.
21. Carruthers J, Carruthers A. The use of botulinum toxin type A in the upper face. Facial Plast Surg Clin North Am. 2006;14(3):253-260. (Pubitemid 44207894)
22. Maas CS. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face. Facial Plast Surg Clin North Am. 2006;14(3):241-245.
23. Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N, for the Botox Glabellar Lines II Study Group. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg. 2003;112(4):1089-1098.
24. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol. 2002;47(6):834-840. (Pubitemid 35403040)
25. Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol. 2006;17(5):471-479.
26. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg. 118(4):98e-106e.
27. Small R. Dermal fillers for facial rejuvenation. In: Mayeaux EJ, ed. The Essential Guide to Primary Care Procedures. Philadelphia, Pa.: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009:214-233.
28. Fagien S, Klein AW. A brief overview and history of temporary fillers: evolution, advantages, and limitations. Plast Reconstr Surg. 2007;120(6 suppl):8S-16S. (Pubitemid 350306741)
29. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369-376.
30. Born T. Hyaluronic acids. Clin Plast Surg. 2006;33(4):525-538.
31. Niamtu J III. Facial aging and regional enhancement with injectable fillers. Cosmet Dermatol. 2007;20(5 suppl 2):14-20.
32. Baumann LS, Shamban AT, Lupo MP, et al., for the Juvederm vs. Zyplast Nasolabial Fold Study Group. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg. 2007;33(suppl 2):S128-S135.
33. Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC III. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008;121(1):289-297.
34. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588-595. (Pubitemid 36702442)
35. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491-497.
36. Haedersdal M, Gøtzsche PC. Laser and photoepilation for unwanted hair growth. Cochrane Database Syst Rev. 2006;(4):CD004684. (Pubitemid 46841254)
37. Dierickx CC. Hair removal by lasers and intense pulsed light sources. Semin Cutan Med Surg. 2000;19(4):267-275.
38. Haedersdal M, Wulf HC. Evidence-based review of hair removal using laser and light sources. J Eur Acad Dermatol Venereol. 2006;20(1):9-20.
39. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524-527.
40. Lask G, Elman M, Slatkine M, Waldman A, Rozenberg Z. Laser-assisted hair removal by selective photothermolysis. Preliminary results. Dermatol Surg. 1997;23(9):737-739. (Pubitemid 27407449)
41. Altshuler GB, Anderson RR, Manstein D, Zenzie HH, Smirnov MZ. Extended theory of selective photothermolysis. Lasers Surg Med. 2001;29(5):416-432.
42. Klavuhn KG, Green D. Importance of cutaneous cooling during photothermal epilation: theoretical and practical considerations. Lasers Surg Med. 2002;31(2):97-105. (Pubitemid 34983113)
43. Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed. 2000;16(6):239-244.
44. Habif TP. Hair diseases. In: Clinical Dermatology. 4th ed. St. Louis, Mo.: Mosby;2003:912-950.
45. Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg. 2000;26(9):835-842.
46. Weiss RA, Weiss MA, Beasley KL. Rejuvenation of photoaged skin: 5 years results with intense pulsed light of the face, neck, and chest. Dermatol Surg. 2002;28(12):1115-1119.
47. Adamic M, Troilius A, Adatto M, Drosner M, Dahmane R. Vascular lasers and IPLS: guidelines for care from the European Society for Laser Dermatology (ESLD). J Cosmet Laser Ther. 2007;9(2):113-124. (Pubitemid 46897787)
48. Small R. Laser photo rejuvenation. In: Mayeaux EJ, ed. The Essential Guide to Primary Care Procedures. Philadelphia, Pa.: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009:249-264.
49. Fabbrocini G. Chemical peels. http://emedicine.medscape.com/article/ 1125365-overview. Accessed November 11, 2009.
50. Coimbra M, Rohrich RJ, Chao J, Brown SA. A prospective controlled assessment of microdermabrasion for damaged skin and fine rhytides. Plast Reconstr Surg. 2004;113(5):1438-1443. (Pubitemid 39201877)
51. Berardesca E, Distante F, Vignoli GP, Oresajo C, Green B. Alpha hydroxy-acids modulate stratum corneum barrier function. Br J Dermatol. 1997;137(6):934-938. (Pubitemid 28011134)
52. Shim EK, Barnette D, Hughes K, Greenway HT. Microdermabrasion: a clinical and histopathologic study. Dermatol Surg. 2001;27(6):524-530.
53. Lee HS, Kim IH. Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg. 2003;29(12):1196-1199.
54. Kessler E, Flanagan K, Chia C, Rogers C, Glaser DA. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg. 2008;34(1):45-50. (Pubitemid 350308584)
55. Sadick NS, Finn N. A review of microdermabrasion. Cosmet Dermatol. 2005;18(5):351-354.
56. Briden ME. Alpha-hydroxyacid chemical peeling agents: case studies and rationale for safe and effective use. Cutis. 2004;73(2 suppl):18-24.
57. Tung RC, Bergfeld WF, Vidimos AT, Remzi BK. Alpha-hydroxy acid-based cosmetic procedures. Guidelines for patient management. Am J Clin Dermatol. 2000;1(2):81-88.
58. Kligman D. Technologies for cutaneous exfoliation using salicylic acid. Dermatol Ther. 2001;14(3):225-227. (Pubitemid 32952618)